US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Globus Medical, Inc. Class A Common Stock (NY:GMED)

81.41 -0.25 (-0.31%)
Official Closing Price Updated: 7:00 PM EDT, Oct 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Globus Medical (NYSE:GMED): A Balanced Affordable Growth Case ↗
Via Chartmill
News headline image
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
New Innovations Designed to Advance Patient-Specific Planning and Connected Surgical Workflows 
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Globus Medical (NYSE:GMED): A Quality Investing Case Built on Durable Growth ↗
Via Chartmill
News headline image
1 Mid-Cap Stock for Long-Term Investors and 2 We Ignore
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe... 
Via StockStory
Globus Medical (NYSE:GMED): A Decent Value Stock With Solid Fundamentals ↗
Via Chartmill
Globus Medical (NYSE:GMED): A Compelling Affordable Growth Opportunity ↗
Via Chartmill
Globus Medical (NYSE:GMED) Shares Rise on Q2 Earnings Beat and Raised Profit Guidance ↗
Via Chartmill
Topics Earnings
Globus Medical (GMED) Emerges as a Decent Value Stock with Strong Fundamentals ↗
Via Chartmill
News headline image
2 Reasons to Watch GMED and 1 to Stay Cautious
Over the last six months, Globus Medical’s shares have sunk to $74.94, producing a disappointing 10.3% loss - a stark contrast to the S&P 500’s 21.4% gain. T... 
Via StockStory
Topics Stocks
News headline image
Q2 Earnings Highs And Lows: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including Gl... 
Via StockStory
News headline image
3 Profitable Stocks on Our Watchlist
Profitable companies tend to be more resilient, giving them the flexibility to invest and return capital to shareholders. Businesses that consistently genera... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stocks on Our Watchlist and 2 Facing Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
Globus Medical Inc - A (NYSE:GMED) Screens Well as a GARP Stock with Strong Growth and Reasonable Valuation ↗
Via Chartmill
Globus Medical (NYSE:GMED) Shines in Navellier’s Little Book Growth Stock Screen ↗
Via Chartmill
Globus Medical Inc - A (NYSE:GMED) Passes the Caviar Cruise Quality Stock Screener with Flying Colors ↗
Via Chartmill
Globus Medical Inc - A (NYSE:GMED) Screens as an Affordable Growth Opportunity with Solid Fundamentals ↗
Via Chartmill
News headline image
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System
Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union 
From Globus Medical
Via GlobeNewswire
News headline image
1 Growth Stock to Stash and 2 We Turn Down
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil... 
Via StockStory
News headline image
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Q2 Earnings Call Highlights ↗
Globus Medical (NYSE:GMED) reported second-quarter 2026 revenue of $789.6 million, up 6% from a year earlier, as growth in its spine and trauma businesses helped offset declines in enabling... 
Via MarketBeat
Topics Earnings
Globus Medical (NYSE:GMED) Shines in Navellier's Little Book Growth Stock Screen ↗
Via Chartmill
News headline image
Globus Medical (NYSE:GMED) Beats Q2 CY2026 Sales Expectations
Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q2 CY2026, with sales up 5.9% year on year to $789.6 million. The... 
Via StockStory
News headline image
Globus Medical Reports Second Quarter 2026 Results
From Globus Medical
Via GlobeNewswire
News headline image
What To Expect From Globus Medical’s (GMED) Q2 Earnings
Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results this Thursday afternoon. Here’s what you need to know. Globus Medical b... 
Via StockStory
News headline image
3 Medical Device Stocks Giving Investors a Different Healthcare Play ↗
Globus Medical, Inspire Medical Systems, and Penumbra show varied revenue growth and analyst ratings, offering medical device investors alternatives to traditional pharmaceutical stocks. 
Via MarketBeat
News headline image
2 Cash-Heavy Stocks with Exciting Potential and 1 We Avoid
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o... 
Via StockStory
Topics Retirement
News headline image
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after a key industry player warned that changes to some insurance plans could slow U.S. proce... 
Via StockStory
News headline image
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
News headline image
3 Cash-Heavy Stocks to Target This Week
A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital. Fin... 
Via StockStory
Topics Initial Public Offering
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >